The risk of optic atrophy following suramin treatment of ocular onchocerciasis.
Treatment of onchocerciasis with suramin in an area of vector control led to an increased incidence of optic atrophy in treated patients compared to an untreated group.
D005128:Eye Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D009855:Onchocerciasis / Q000188:drug therapy*; D009896:Optic Atrophy / Q000139:chemically induced*; D013498:Suramin / Q000009:adverse effects*
D013498:Suramin